Cite
MLA Citation
Martine Bagot et al.. “Lacutamab in patients (pts) with advanced mycosis fungoides (MF) according to KIR3DL2 expression: early results from the TELLOMAK phase 2 trial.” European journal of cancer, vol. 156, n.d., pp. S20–S21. http://access.bl.uk/ark:/81055/vdc_100144489911.0x000031